Case Report Shows Carbimazole's ‘Triple-Hit’ - Takeaway - MDSpire
From the Journals

Case Report Shows Carbimazole's ‘Triple-Hit’

Diffuse alveolar hemorrhage with coexistent antiphospholipid syndrome complicated anticoagulation therapy and created competing bleeding and thrombosis risks.

Share

  • 1

    Patient had hyperthyroidism treated for 15 years with carbimazole.

  • 2

    Developed vasculitis and antiphospholipid syndrome.

  • 3

    Experienced hemoptysis and respiratory failure.

  • 4

    Managed with plasmapheresis and immunosuppressive therapy.

  • 5

    Achieved clinical remission after treatment.

  • 6

    Carbimazole was cautiously reintroduced.

  • 7

    Anti-thrombotic treatment was adjusted due to bleeding risks.

  • 8

    Case illustrates complex interrelations in treatment management.

Original Source(s)

Case Report Shows Carbimazole's ‘Triple-Hit’

  • by Andrea Surnit

  • April 1, 2026

Related Content

TENS Added to Physical Therapy Lowers Fibromyalgia Pain

Adjunctive transcutaneous electrical nerve stimulation improves movement-evoked pain and fatigue in pragmatic trial

EULAR Updates Behçet’s Syndrome Recommendations

EULAR releases updated recommendations supporting earlier biologic use in patients with eye, vascular, and nervous system involvement

Knee OA Pain: Inulin vs Physiotherapy Effects

Prebiotic supplementation and physiotherapy show distinct and complementary effects on functional and pain sensitivity outcomes.